An update of the medical treatment of malignant endocrine pancreatic tumors

Acta Oncologica

Volumn 32, Issue 2, 1993, Pages 203-208

  Eriksson, Barbro ^a   Öberg, Kjell ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON A; ALPHA2B INTERFERON; DOXORUBICIN; FLUOROURACIL; OCTREOTIDE; RECOMBINANT ALPHA2B INTERFERON; STREPTOZOCIN;

ADULT; AGED; CONFERENCE PAPER; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; METASTASIS; PANCREAS ISLET CELL TUMOR; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADENOMA, ISLET CELL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CLINICAL TRIALS; FEMALE; FLUOROURACIL; GASTRINOMA; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; OCTREOTIDE; PANCREATIC NEOPLASMS; STREPTOZOCIN; VIPOMA;

EID: 0027157087     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.3109/02841869309083913     Document Type: Article

References (14)

1. Treatment of malignant endocrine pancreatic tumors with human leukocyte interferon
2. Treatment of metastatic islet cell carcinoma with a somatostatin analogue
3. Clinical presentation, biochemical and histopathological findings in 84 patients with neuroendocrine pancreatic tumors
4. Pancreatic islet cell carcinoma I. Clinical features of 52 patients
5. Streptozocin alone compared with streptozocin plus flurouracil in the treatment of advanced islet cell carcinoma
6. Medical treatment and long-term survival in a prospective study of 84 patients with endocrine pancreatic tumors
7. A polyclonal antiserum against chromogranin A and B: A new sensitive marker for neuroendocrine tumors
8. Streptozocin-doxorubicin, stretpzocin-fluorouracil, or chloro-zotocin in the treatment of advanced islet-cell carcinoma
9. Interferon-induced enhancement of 2–5-oligoadenylate synthetase in mid-gut carcinoid tumors
10. Interferons in the management of multiple myeloma
11. Octreotide and interferon alfa: a new combination for the treatment of malignant carcinoid tumors
12. 1) Octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabel-ling and in vitro validation
13. Somatostatin and somatostatin analogues in oncology
14. Inhibition of growth of pancreatic carcinomas in animal models by analogs of hyopthalamic hormones